No Image
Polyclonal Antibodies
Anti-ELOVL4 Rabbit Polyclonal Antibody for WB, IF/ICC, ELISA - Q9GZR5
Item Number : CM0027697
Price varies based on specs and customizations
- Application
- WB, IF/ICC, ELISA
- Cross Reactivity
- Human, Mouse, Rat
- Protein Weight
- 37kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | ELOVL4 Rabbit pAb |
| Remarks/Alias | ADMD; CT118; ISQMR; SCA34; STGD2; STGD3; ELOVL4 |
| Species | Human |
| GeneID (Human) | 6785 |
| GeneID | 6785 |
| Immunogen | Synthetic peptide|A synthetic peptide corresponding to a sequence within amino acids 1-100 of human ELOVL4 (NP_073563.1). |
| Source | Rabbit |
| Category | Polyclonal Antibodies |
| Application | WB, IF/ICC, ELISA |
| Cross Reactivity | Human, Mouse, Rat |
| SWISS | Q9GZR5 |
| Protein Weight | 37kDa |
| Shipping | Ice bag |
Biological Background: ELOVL4 Function and Localization
- ELOVL4 (ELOVL fatty acid elongase 4) is a very long chain fatty acid elongase, also known as 3-keto acyl-CoA synthase ELOVL4, and is implicated in Stargardt disease type 3 (STGD3) and other disorders.
- It catalyzes the first and rate-limiting step of the cycle that adds two carbon units to long-chain and very long-chain fatty acids, a process essential for the synthesis of saturated and polyunsaturated VLCFAs.
- ELOVL4 is an integral endoplasmic reticulum membrane protein, consistent with its role in lipid elongation occurring at the ER membrane.
- The enzyme produces VLC-SFA and PUFA that serve as precursors for membrane lipids and signaling mediators, highlighting its importance in cellular membrane composition and lipid mediator biosynthesis.
- It may play a critical role in early brain and skin development, based on functional studies and disease associations (e.g., ichthyosis and intellectual disability).
- ELOVL4 is highly expressed in the retina, with lower expression in the brain, thymus, testis, small intestine, ovary, and prostate; minimal expression in heart, lung, liver, or leukocytes.
- Known disease variants are linked to Stargardt disease, spinocerebellar ataxia, ichthyosis, and intellectual disability, reflecting its crucial neurodevelopmental and dermatological functions.
Experimental Guidance and Technical Tips
- The immunogen is a synthetic peptide from the N-terminus (amino acids 1-100) of human ELOVL4; for critical applications, consider peptide blocking to confirm signal specificity.
- For Western blot, expect a band near 37 kDa; validate in appropriate tissue or cell lysates, such as retinal or brain extracts, which are known to express ELOVL4.
- In IF/ICC, anticipated localization is the endoplasmic reticulum; use co-staining with ER markers to verify subcellular distribution.
- Cross-reactivity is reported for human, mouse, and rat; before use in other species, check sequence homology and test in pilot experiments.
- ELISA applications may require optimization of coating concentration and blocking conditions; titrate antibody for best signal-to-noise ratio.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio connects diagnostic manufacturers and research labs with a comprehensive portfolio of IVD raw materials, including validated antibodies like this anti-ELOVL4 rabbit polyclonal antibody for lipid metabolism and retinal disease research. Beyond individual antibodies, we offer optimized monoclonal and polyclonal antibody panels, bulk ancillary reagents, and custom sourcing for rare targets. Let our expert team support your assay development pipeline from concept to clinic.
Product Datasheet
Anti-ELOVL4 Rabbit Polyclonal Antibody for WB, IF/ICC, ELISA - Q9GZR5
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!